Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Better Buy: AT&T vs. Amazon: https://g.foolcdn.com/editorial/images/736707/family-piggy-bank.jpg
Better Buy: AT&T vs. Amazon

AT&T (NYSE: T) and Amazon (NASDAQ: AMZN) are both often considered stable long-term investments. AT&T is one of the largest telecom companies in the United States, and it has paid continuous

After Blasting Off 881% in 1 Year, Is Viking Therapeutics Still a Good Buy?: https://g.foolcdn.com/editorial/images/736473/scientists-lab-testing-vaccine-development1.jpg
After Blasting Off 881% in 1 Year, Is Viking Therapeutics Still a Good Buy?

Viking Therapeutics (NASDAQ: VKTX) is up 881% in the last 12 months thanks to its ongoing development of a pair of therapies to treat obesity and metabolic disorders like diabetes. As you may have

EQS-News: Evotec SE Annual General Meeting 2023 approves all proposed agenda items: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
EQS-News: Evotec SE Annual General Meeting 2023 approves all proposed agenda items
EQS-News: Evotec SE Annual General Meeting 2023 approves all proposed agenda items
Where Will Axsome Therapeutics Be in 3 Years?: https://g.foolcdn.com/editorial/images/736806/gettyimages-1147525564.jpg
Where Will Axsome Therapeutics Be in 3 Years?

Last year was a big one for Axsome Therapeutics (NASDAQ: AXSM). The biotech company specialized in central nervous system conditions launched its first two products and saw its share price increase

Best Dividend Stock to Buy: AT&T vs. Deere: https://g.foolcdn.com/editorial/images/736838/untitled-design-32.png
Best Dividend Stock to Buy: AT&T vs. Deere

Fool.com contributor and finance professor Parkev Tatevosian compares AT&T (NYSE: T) and Deere (NYSE: DE) to determine which is the better dividend stock to buy.

*Stock prices used were the

What Do Bears Know About Novavax That Bulls Don't?: https://g.foolcdn.com/editorial/images/736798/gettyimages-healthcare-worker-prepares-vaccine-dose.jpg
What Do Bears Know About Novavax That Bulls Don't?

Novavax (NASDAQ: NVAX) soared early in the coronavirus vaccine race. The stock climbed more than 2,700% in 2020.

But as the biotech company fell behind in the race, so did its shares. Novavax

If You Own These 3 Growth Stocks, You Might Want to Rethink Your Position: https://g.foolcdn.com/editorial/images/736546/healthcare-lab-treatment-research-scientist-1.jpg
If You Own These 3 Growth Stocks, You Might Want to Rethink Your Position

Nano-X Imaging (NASDAQ: NNOX), DermTech (NASDAQ: DMTK), and Viking Therapeutics (NASDAQ: VKTX) are healthcare growth stocks with plenty of potential, little revenue, and a boatload of risk.

Share

Why Investors Should Care About Novartis' Latest Label Expansion -- It Could Mean Billions: https://g.foolcdn.com/editorial/images/736519/a-customer-shops-at-a-pharmacy.jpg
Why Investors Should Care About Novartis' Latest Label Expansion -- It Could Mean Billions

Earlier this month, Novartis' (NYSE: NVS) smash-hit immunology medicine Cosentyx became the first drug within its class to be approved in the European Union to treat adult patients with moderate to

Intellia Therapeutics Stock Could Roar in the Next Bull Market. Here's Why.: https://g.foolcdn.com/editorial/images/736480/scientists-lab-testing-blood-draw1.jpg
Intellia Therapeutics Stock Could Roar in the Next Bull Market. Here's Why.

Even after rising 30% so far this year, shares of Intellia Therapeutics (NASDAQ: NTLA) could easily experience another leg up if there's a bull market in the latter half of 2023. With positive

Does This Signal Trouble for Biogen's New Alzheimer's Drug?: https://g.foolcdn.com/editorial/images/736443/gettyimages-pensive-investor-at-computer.jpg
Does This Signal Trouble for Biogen's New Alzheimer's Drug?

Biogen (NASDAQ: BIIB) recently got some good news in the U.S. An advisory committee for the Food and Drug Administration (FDA) unanimously confirmed the clinical benefit of its Alzheimer's drug

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Nvidia Is About to Change Gaming Forever With AI: https://g.foolcdn.com/editorial/images/736434/ai-software.jpg
Nvidia Is About to Change Gaming Forever With AI

Nvidia's (NASDAQ: NVDA) explosive growth in its data center segment recently overtook gaming as the company's largest source of revenue. But gaming is still a large business, generating a third of

2 Market-Beating Stocks With Major Catalysts on the Way: https://g.foolcdn.com/editorial/images/736385/physician-giving-medicine-to-elderly-patient.jpg
2 Market-Beating Stocks With Major Catalysts on the Way

For those seeking stocks that have trounced the market over the past year, the biotech sector might be an excellent place to start. The SPDR S&P Biotech Index ETF, an industry benchmark, has climbed

3 Cathie Wood Investments That Could Deliver Superior Returns: https://g.foolcdn.com/editorial/images/736111/dna-genetic-sequencing-biotech-1.jpg
3 Cathie Wood Investments That Could Deliver Superior Returns

Cathie Wood, the CEO of Ark Investment, has made a name for herself by betting on cutting-edge technology with financial technology stocks, or fintechs, and biotechnology growth stocks making up a

Could Viking Therapeutics Stock Help You Become a Millionaire?: https://g.foolcdn.com/editorial/images/736139/a-team-of-scientists-reviewing-results-in-a-lab.jpg
Could Viking Therapeutics Stock Help You Become a Millionaire?

An up-and-coming stock with lots of potential is Viking Therapeutics (NASDAQ: VKTX). Investors have been piling money into the biotech stock this year, as it has surged 150% since January. And at a

3 Bargain Stocks to Buy on the Dip: https://g.foolcdn.com/editorial/images/736534/stock-chart-trending-down-with-man.jpg
3 Bargain Stocks to Buy on the Dip

Buy on the dip. Most investors have heard the old saying. However, it's only good advice when a stock is likely to rebound strongly.

Three Motley Fool contributors think they've identified stocks

Does an $11.5 Billion Opportunity Make This Growth Stock a Buy Now?: https://g.foolcdn.com/editorial/images/736432/a-person-delivering-a-presentation-getty.jpg
Does an $11.5 Billion Opportunity Make This Growth Stock a Buy Now?

Axsome Therapeutics (NASDAQ: AXSM) stock jumped more than 10% on June 14 after the company made its latest investor presentation public. The market was reacting to new estimates that suggest peak

This Stock Crushed the Market Last Year. Here's Why It Could Do That Again.: https://g.foolcdn.com/editorial/images/736440/gettyimages-1272759382.jpg
This Stock Crushed the Market Last Year. Here's Why It Could Do That Again.

Axsome Therapeutics (NASDAQ: AXSM) started out last year as a small up-and-coming biotech company. It finished the year with a more than 100% gain, beating the bear market and crushing the S&P 500

Why Shares of Schrödinger Rose This Week: https://g.foolcdn.com/editorial/images/736624/a-scientist-uses-a-pipette-to-work-with-medical-samples.jpg
Why Shares of Schrödinger Rose This Week

Shares of Schrödinger (NASDAQ: SDGR) were up by 28.6% for the week on Friday morning after rising as high as 30.8%, according to data provided by S&P Global Market Intelligence. The drug discovery

This Biotech Is About to Eat AbbVie's Market Share, but Is It a Buy?: https://g.foolcdn.com/editorial/images/736191/chart-reflected-on-investor-glasses.jpg
This Biotech Is About to Eat AbbVie's Market Share, but Is It a Buy?

Soon enough, there's a big chance that the plucky biotech Coherus Biosciences (NASDAQ: CHRS) is going to be eating AbbVie's (NYSE: ABBV) lunch. Assuming it does, it's not going to be stealing a fry

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Is Axsome Therapeutics Stock a Screaming Buy?: https://g.foolcdn.com/editorial/images/736435/pig-taking-flight.jpg
Is Axsome Therapeutics Stock a Screaming Buy?

The best biotech growth stocks typically have one clear-cut value driver. This fact is a testament to the extreme difficulty involved in bringing a major new drug to market and subsequently

Why Shares in Abcam Surged This Week: https://g.foolcdn.com/editorial/images/736489/plan-ahead-sign.jpg
Why Shares in Abcam Surged This Week

Shares in UK-based life sciences company Abcam (NASDAQ: ABCM) were up 12.7% in the week at 11 a.m. ET. The move comes in an exciting week of news for the company, involving an unhappy founder, a

Earn Dividends EVERY Month With These 3 Stocks: https://g.foolcdn.com/editorial/images/736397/youtube-thumbnails-50.png
Earn Dividends EVERY Month With These 3 Stocks

You can earn monthly dividend income in a few ways:

Today, I look at three blue chip stocks that are trading at reasonable valuations and will have you receiving a dividend paycheck every month. One

2 Stocks Down 11% and 20% to Buy Right Now: https://g.foolcdn.com/editorial/images/736303/gettyimages-investor-uses-tablet-and-phone.jpg
2 Stocks Down 11% and 20% to Buy Right Now

When looking for bargains at a store, you might go to the sale rack. With the stock market, you might look to some of the stocks that have tumbled over the past several months. Even though the three